Company Overview and News

 
Moody's upgrades Vedanta Resources' corporate family rating to Ba3

2017-11-20 business-standard
Moody's Investors Service today upgraded London-based Vedanta Resources Plc's corporate family rating (CFR) and senior unsecured bond rating and placed a stable rating outlook for the company.
Upvote Downvote

 
Fura Appoints Key Executives in Marketing, Sales and Colombian Operations

2017-11-15 marketwired
TORONTO, ONTARIO--(Marketwired - Nov. 15, 2017) - Fura Gems Inc. (TSX VENTURE:FUR) is pleased to announce the appointment of Rupak Sen as Vice President - Marketing and Sales and Armando Diaz as Project Manager - Colombia.
Upvote Downvote

 
Vedanta Resources' (VDNRF) CEO Kuldip Kalra on Q2 2018 Results - Earnings Call Transcript

2017-11-11 seekingalpha
Thank you for joining us today for our H1 FY 2018 Results and Capital Markets Day. Let me introduce our speakers and go over the agenda for today. Our Chairman, Anil Agarwal will give an overview followed by a strategy update by our CEO, Kuldip Kaura. This will be followed by Scott Caithness, our Head of Exploration who's here on video. Our CFO, Arun Kumar is unable to join us today for medical reasons, so I will cover the financial update.
Upvote Downvote

1
UPDATE 1-UK Stocks-Factors to watch on Nov 10

2017-11-10 reuters
Nov 10 (Reuters) - Britain’s FTSE 100 index is seen opening 13 points higher at 7,497 on Friday, according to financial bookmakers, with futures up 0.11 percent ahead of the cash market open.
Upvote Downvote

 
Miner Vedanta's first-half profit jumps 37 percent on higher output, prices

2017-11-10 in.reuters
(Reuters) - Diversified miner Vedanta Resources’ (VED.L) said its half-year profit rose 37.4 percent, helped by higher commodity prices and production.
Upvote Downvote

 
NMDC plans to bid for $9 billion diamond mine in Madhya Pradesh

2017-11-07 livemint
New Delhi: State-owned miner NMDC Ltd plans to bid for a $9 billion diamond project in Madhya Pradesh, three people directly involved with the plan told Reuters, competing against resources conglomerates Adani and Vedanta.
Upvote Downvote

 
State miner NMDC may bid for $9 bn diamond project in Madhya Pradesh

2017-11-07 business-standard
India's state-owned miner NMDC Ltd plans to bid for a $9 billion diamond project in Madhya Pradesh, three sources directly involved with the plan told Reuters, competing against resources conglomerates Adani and Vedanta.
Upvote Downvote

 
Exclusive: State miner NMDC plans bid for $9 billion diamond mine, sources say

2017-11-07 in.reuters
NEW DELHI (Reuters) - India’s state-owned miner NMDC Ltd (NMDC.NS) plans to bid for a $9 billion diamond project in Madhya Pradesh, three sources directly involved with the plan told Reuters, competing against resources conglomerates Adani and Vedanta.
Upvote Downvote

 
Vedanta Q2 net up 47% to Rs 2,091 crore, misses estimates

2017-11-02 business-standard
Vedanta Ltd, the Indian unit of diversified mining group Vedanta Resources Plc, posted a 47 per cent rise in second-quarter profit, helped by improved commodity prices and higher zinc and copper production.
Upvote Downvote

 
Vedanta Q2 profit rises 47% to Rs2,091 crore

2017-11-02 livemint
Bengaluru: Vedanta Ltd, the Indian unit of diversified mining group Vedanta Resources Plc, posted a 47% rise in second-quarter profit, helped by improved commodity prices and higher zinc and copper production.
Upvote Downvote

 
Vedanta posts 47 percent rise in second-profit profit, but misses estimates

2017-11-02 in.reuters
REUTERS - Vedanta Ltd (VDAN.NS), the Indian unit of diversified mining group Vedanta Resources Plc (VED.L), posted a 47 percent rise in second-quarter profit, helped by improved commodity prices and higher zinc and copper production.
Upvote Downvote

 
Vedanta to invest $9 billion in India#39;s resources sector to meet domestic demand

2017-10-31 moneycontrol
Mining giant Vedanta Resources Plc's executive chairman Anil Agarwal said that the company is planning to invest USD 9 billion in India in sectors such as oil and gas, production of aluminium, zinc, copper, silver and steel and mining of bauxite and rock phosphate.
Upvote Downvote

 
News Live: Vedanta to invest $9bn in India

2017-10-31 moneycontrol
The Jaipur Municipal Corporation (JMC) began the practice of playing the national anthem at start of day and the national song in the evening at its headquarters, and directed all its staffers to be present, reports PTI. By the end of this month, the national anthem and song would be played at all zonal offices and fire stations, Mayor Ashok Lahoti said. He said the first stanza of the national song would be played on speakers and the employees can then go home.
Upvote Downvote

 
News Live: Modi govt eyes ‘big jump’ in World Bank’s Ease of Doing Business report

2017-10-31 moneycontrol
Bain Capital is in advanced talks with Axis Bank to invest between $750 million and $1 billion (Rs 4,800-6,400 crore), in what could be one of the largest private equity investments in the Indian banking sector, reports The Economic Times. India’s third-biggest private lender is in talks to raise money amidst worsening asset quality and regulatory glare. Bain’s proposed investment will come as a primary issuance of shares through a preferential allotment that will allow the PE fund to own up to 5% of Axis Bank.
Upvote Downvote

 
Deals Buzz: Bain Capital to invest $1 billion in Axis Bank

2017-10-31 livemint
Mumbai: Mint brings to you your daily dose of top deals reported by newsrooms across the country.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...